AILERON THERAPEUTICS INC
SEC Filing List
ALRN CIK: 0001420565
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 10-K | Annual report pursuant to Section 13 and... | Rein Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/26/2026 | |
| 8-K | Current report filing | Rein Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/02/2026 | |
| 8-K | Current report filing | Rein Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 02/19/2026 | |
| SCHEDULE 13G/A | OLSHAN FROME WOLOSKY LLP /fa | 02/13/2026 | |||
| 8-K | Current report filing | Rein Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 01/16/2026 | |
| 8-K | Current report filing | Rein Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 12/11/2025 | |
| 4 | Statement of changes in beneficial owner... | OLSHAN FROME WOLOSKY LLP /fa | 11/18/2025 | ||
| 10-Q | Quarterly report pursuant to Section 13 ... | Rein Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 11/14/2025 | |
| 8-K | Current report filing | Rein Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 11/03/2025 | |
| 4 | Statement of changes in beneficial owner... | OLSHAN FROME WOLOSKY LLP /fa | 10/28/2025 | ||
| No record found. | |||||
| Load More | |||||
